Brief: Lee's Pharmaceutical Says Trazodone Hydrochloride Tablet Obtained Drug Registration Certificate From NMPA
11/12/2020 14:29
Dec 11 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* TRAZODONE HYDROCHLORIDE TABLET OBTAINED DRUG REGISTRATION
CERTIFICATE FROM CHINA'S NMPA
* TRITTICO FOR TREATMENT OF DEPRESSION
Source text for Eikon: ID:nHKSbYZZtr
Further company coverage: 0950.HK
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA